The U.K. Medicines and Healthcare products Regulatory Agency on Friday said it's given approval for the first monoclonal antibody treatment for the prevention and treatment of COVID-19. Ronapreve, made by Regeneron
REGN,
+3.16%
and Roche
ROG,
-1.01%,
may be used to prevent infection, promote resolution of symptoms of acute COVID-19 infection and reduce hospitalization, the regulator said. AstraZeneca
AZN,
-0.42%
separately on Friday said it would seek regulatory approval for its antibody cocktail treating COVID-19.